Diffusion-weighted and dynamic contrast-enhanced imaging as markers of clinical behavior in children with optic pathway glioma

Pediatric Radiology

Volumn 38, Issue 12, 2008, Pages 1293-1299

  Jost, Sarah C ^a   Ackerman, Joseph W ^b   Garbow, Joel R ^b,c   Manwaring, Linda P ^b   Gutmann, David H ^b,c   McKinstry, Robert C ^b  

^a SWEDISH MEDICAL CENTER   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c USA   (United States)

Author keywords

Diffusion weighted MRI; Dynamic contrast MRI; Glioma; Neurofibromatosis; Optic pathway

Indexed keywords

ANTINEOPLASTIC AGENT; BIOLOGICAL MARKER; CONTRAST MEDIUM; GADOLINIUM;

AGGRESSIVENESS; ARTICLE; CHILD; CLINICAL ARTICLE; CORRELATION ANALYSIS; CROSS-SECTIONAL STUDY; DIAGNOSTIC IMAGING; DIFFUSION WEIGHTED IMAGING; DISEASE ACTIVITY; DISEASE MARKER; DYNAMIC CONTRAST ENHANCED IMAGING; EQUIPMENT; HUMAN; NEUROFIBROMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE GLIOMA; PERMEABILITY; PHENOTYPE; PRIORITY JOURNAL; TUMOR VOLUME; VISUAL ACUITY;

CAPILLARY PERMEABILITY; CHILD; CONTRAST MEDIA; CROSS-SECTIONAL STUDIES; DIFFUSION MAGNETIC RESONANCE IMAGING; GADOLINIUM; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; IMAGING, THREE-DIMENSIONAL; OPTIC CHIASM; OPTIC NERVE GLIOMA; PREDICTIVE VALUE OF TESTS; TREATMENT OUTCOME;

EID: 55949135739     PISSN: 03010449     EISSN: 14321998     Source Type: Journal    
DOI: 10.1007/s00247-008-1003-x     Document Type: Article

References (30)

1. Louis DN, Ohgaki H, Wiestler OD et al (2007) WHO classification of tumours of the central nervous system. IARC, Lyon, France
2. JM Friedman 1989 Epidemiology of neurofibromatosis type 1 Am J Med Genet 89 1 6
3. Friedman JM, Gutmann DH, MacCollin MM et al (1999) Neurofibromatosis, 3rd edn. Johns Hopkins Press, Baltimore
4. R Listernick DN Louis RJ Packer 1997 Optic pathway gliomas in children with NF1: consensus statement from the NF1 Optic Pathway Glioma Task Force Ann Neurol 41 143 149
5. R Listernick RE Ferner GT Liu 2007 Optic pathway glioma in neurofibromatosis-1: controversies and recommendations Ann Neurol 61 189 198
6. A King R Listernick J Charrow 2003 Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome Am J Med Genet 122A 95 99
7. E Czyzyk S Jozwiak M Roszkowski 2003 Optic pathway gliomas in children with and without neurofibromatosis 1 J Child Neurol 18 471 478
8. MF Shamji BG Benoit 2007 Syndromic and sporadic pediatric optic pathway gliomas: review of clinical and histopathological differences and treatment implications Neurosurg Focus 23 E3
9. S Singhal HM Birch B Kerr 2002 Neurofibromatosis type 1 and sporadic optic gliomas Arch Dis Child 87 65 70
10. SL Tow S Chandela NR Miller 2003 Long-term outcome in children with gliomas of the anterior visual pathway Pediatr Neurol 28 262 270
11. C Adams WA Fletcher ST Myles 1997 Chiasmal glioma in neurofibromatosis type 1 with severe visual loss regained with radiation Pediatr Neurol 17 80 82
12. MP Champion RO Robinson 1995 Screening for optic gliomas in neurofibromatosis type 1. The role of neuroimaging J Pediatr 127 507 508
13. AE Brzowski C Bazan JV Mumma 1992 Spontaneous regression of optic glioma in a patient with neurofibromatosis Neurology 42 679 681
14. GT Liu S Lessel 1992 Spontaneous visual improvement in chiasmal gliomas Am J Ophthalmol 114 193 201
15. C Parazzini F Triulzi E Bianchini 1995 Spontaneous involution of optic pathway lesions in neurofibromatosis type 1: serial contrast MR evaluation AJNR 16 1711 1718
16. A Shuper G Horev L Kornreich 1997 Visual pathway glioma: an erratic tumour with therapeutic dilemmas Arch Dis Child 76 259 263
17. DH Gutmann A Aylsworth JC Carey 1997 The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2 JAMA 278 51 57
18. JR Ewing RA Knight TN Nagaraja 2003 Patlak plots of Gd-DTPA MRI data yield blood-brain transfer constants concordant with those of 14C-sucrose in areas of blood-brain opening Magn Reson Med 50 283 292
19. CS Patlak RG Blasberg JD Fenstermacher 1983 Graphical evaluation of blood to brain transfer constants from multiple uptake data J Cereb Blood Flow Metab 3 1 7
20. TL Chenevert PE McKeever BD Ross 1997 Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging Clin Cancer Res 3 1457 1466
21. DE Hall BA Moffat J Stojanovska 2004 Efficacy of DTI-015 using diffusion MRI as an early surrogate marker Clin Cancer Res 10 7852 7859
22. BA Moffat TL Chenevert TS Lawrence 2005 Functional diffusion map: a noninvasive MRI biomarker for stratification of clinical brain tumor response Proc Natl Acad Sci USA 102 5524 5529
23. KM Gauvain RC McKinstry P Mukherjee 2001 Evaluating pediatric brain tumor cellularity with diffusion-tensor imaging AJR 177 449 454
24. Z Rumboldt DL Camacho D Lake 2006 Apparent diffusion coefficients for differentiation of cerebellar tumors in children AJNR 27 1362 1369
25. F Yamasaki K Kurisu K Satoh 2005 Apparent diffusion coefficient of human brain tumors at MR imaging Radiology 235 985 991
26. RN Sener 2001 Diffusion MRI in neurofibromatosis type 1: ADC evaluations of the optic pathways, and a comparison with normal individuals Comput Med Imaging Graph 26 59 64
27. M Pauliah V Saxena M Haris 2007 Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma Magn Reson Imaging 25 1292 1299
28. ML Bajenaru JR Garbow A Perry 2005 Natural history of neurofibromatosis 1-associated optic nerve glioma in mice Ann Neurol 57 119 127
29. M Law S Oh JS Babb 2006 Low-grade gliomas: dynamic susceptibility- weighted contrast-enhanced perfusion MR imaging - prediction of patient clinical response Radiology 238 658 667
30. SP Robinson FA Howe JR Griffiths 2007 Susceptibility contrast magnetic resonance imaging determination of fractional tumor blood volume: a noninvasive imaging biomarker of response to the vascular disrupting agent ZD6126 Int J Radiat Oncol Biol Phys 69 872 879